Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial.

Research paper from Europe PMC. Evidence status: source reported.

Published

2008-10-08

Source reference

MED:18990168

DOI

10.1111/j.1464-410x.2008.08034.x

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Anderson J, Popert RJ, Sanders K, Morgan RC, Stansfeld J, Dwyer J, Masters J, Parmar MK. · BJU Int · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · Found via: ClinicalTrials.gov result publication

Source: https://europepmc.org/article/MED/18990168. Captured 2026-10-24.

Limitations: Listed by a ClinicalTrials.gov registration as a result publication of that study, and fetched by its PubMed ID. The registry's listing is the sponsor's statement; it does not confirm which data the paper used. Preprints may not be peer reviewed.